LandosBio

LandosBio

LandosBio

Landos pursues safer, more effective first-in-class oral therapeutics for autoimmune disorders at an accelerated rate.
Raised
$10M
Follow us
Alexa global traffic share
Twitter followers
21 Sep 2017
$10,000,000
Venture capital (Series A)